Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: a multicenter trial. Dolasetron Mesylate PONV Treatment Study Group.

Kovac AL, Scuderi PE, Boerner TF, Chelly JE, Goldberg ME, Hantler CB, Hahne WF, Brown RA.

Anesth Analg. 1997 Sep;85(3):546-52.

PMID:
9296407
2.

Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group.

Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA.

J Clin Anesth. 1998 Mar;10(2):145-52.

PMID:
9524901
3.

Intravenous dolasetron for the prevention of postoperative nausea and vomiting after outpatient laparoscopic gynecologic surgery.

Graczyk SG, McKenzie R, Kallar S, Hickok CB, Melson T, Morrill B, Hahne WF, Brown RA.

Anesth Analg. 1997 Feb;84(2):325-30.

PMID:
9024022
4.
5.

Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.

Korttila K, Clergue F, Leeser J, Feiss P, Olthoff D, Payeur-Michel C, Wessel P, Nave S, Hahne W, Brown R.

Acta Anaesthesiol Scand. 1997 Aug;41(7):914-22.

PMID:
9265937
6.

Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.

Diemunsch P, Leeser J, Feiss P, D'Hollander A, Bradburn BG, Paxton D, Whitmore J, Panouillot P, Navé S, Brown RA, Hahne WF.

Can J Anaesth. 1997 Feb;44(2):173-81.

PMID:
9043731
7.

Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.

Philip BK, Pearman MH, Kovac AL, Chelly JE, Wetchler BV, McKenzie R, Monk TG, Dershwitz M, Mingus M, Sung YF, Hahne WF, Brown RA.

Eur J Anaesthesiol. 2000 Jan;17(1):23-32.

PMID:
10758440
8.

[Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].

Danner K, Becker HG, Best B, Madler C.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Jul;36(7):425-30. German.

PMID:
11496617
9.

Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery.

Diemunsch P, D'Hollander A, Paxton L, Schoeffler P, Wessel P, Navé S, Brown RA, Hahne WF.

J Clin Anesth. 1997 Aug;9(5):365-73.

PMID:
9257201
10.

A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.

Bey P, Wilkinson PM, Resbeut M, Bourdin S, Le Floch O, Hahne W, Claverie N.

Support Care Cancer. 1996 Sep;4(5):378-83.

PMID:
8883232
11.

A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.

Audhuy B, Cappelaere P, Martin M, Cervantes A, Fabbro M, Rivière A, Khayat D, Bleiberg H, Faraldi M, Claverie N, Aranda E, Auclerc G, Audhuy B, Benhammouda A, Bleiberg H, Cals L, Cappelaere P, Cattan A, Cervantes A, Chevallier B, Conroy T, Cupissol D, De Grève J, Diaz-Rubio E, Seitz JF, et al.

Eur J Cancer. 1996 May;32A(5):807-13.

PMID:
9081358
12.

The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting.

Chen X, Tang J, White PF, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E.

Anesth Analg. 2001 Oct;93(4):906-11.

PMID:
11574355
14.

Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy. The Canadian Dolasetron Study Group.

Warriner CB, Knox D, Belo S, Cole C, Finegan BA, Perreault L.

Can J Anaesth. 1997 Nov;44(11):1167-73.

PMID:
9398956
15.
16.
17.

Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.

Piper SN, Röhm K, Boldt J, Kranke P, Maleck W, Seifert R, Suttner S.

J Craniomaxillofac Surg. 2008 Apr;36(3):173-9. doi: 10.1016/j.jcms.2007.07.011. Epub 2008 Mar 18.

PMID:
18353666
18.

Antiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapy.

Yeilding A, Bertoli L, Eisenberg P, Plezia P, Modiano MR, Alberts DS, Khojasteh A, Cramer MB, Hahne WF.

Am J Clin Oncol. 1996 Dec;19(6):619-23.

PMID:
8931684
19.
20.

A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis.

Harman GS, Omura GA, Ryan K, Hainsworth JD, Cramer MB, Hahne WF.

Cancer Chemother Pharmacol. 1996;38(4):323-8.

PMID:
8674154
Items per page

Supplemental Content

Write to the Help Desk